Drug Shortage Report for 5% DEXTROSE INJECTION, USP

Last updated on 2022-09-02 History
Report ID 150511
Drug Identification Number 00060348
Brand name 5% DEXTROSE INJECTION, USP
Common or Proper name 5% DEXTROSE INJECTION, USP
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) DEXTROSE
Strength(s) 5G
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 100 mL (JB0041P)
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-12-06
Actual start date 2021-12-06
Estimated end date 2022-09-01
Actual end date 2022-09-01
Shortage status Resolved
Updated date 2022-09-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2022-09-02 English Compare
v23 2022-09-01 French Compare
v22 2022-09-01 English Compare
v21 2022-08-23 French Compare
v20 2022-08-23 English Compare
v19 2022-07-29 French Compare
v18 2022-07-29 English Compare
v17 2022-07-20 French Compare
v16 2022-07-20 English Compare
v15 2022-06-10 French Compare
v14 2022-06-10 English Compare
v13 2022-05-26 French Compare
v12 2022-05-26 English Compare
v11 2022-05-13 French Compare
v10 2022-05-13 English Compare
v9 2022-04-12 French Compare
v8 2022-04-12 English Compare
v7 2022-03-24 French Compare
v6 2022-03-24 English Compare
v5 2022-02-14 French Compare

Showing 1 to 20 of 24